Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Issa

Showing results (181-190 of 209) with videos related to

Pageof 21
Sort By:
Blood|August 3, 2006
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemiaHagop Kantarjian, Yasuhiro Oki, Guillermo Garcia-Manero, et al.
Cancer Research|May 31, 2013
Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastomaAtsushi Natsume, Motokazu Ito, Keisuke Katsushima, et al.
Plos One|December 2, 2011
DNA methylation profiles of primary colorectal carcinoma and matched liver metastasisKazuo Konishi, Yoshiyuki Watanabe, Lanlan Shen, et al.
Toxicology Letters|December 3, 2014
Liver DNA methylation analysis in adult female C57BL/6JxFVB mice following perinatal exposure to bisphenol AJ C J van Esterik, A P Vitins, H M Hodemaekers, et al.
The Lancet. Oncology|August 23, 2015
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 studyJean-Pierre J Issa, Gail Roboz, David Rizzieri, et al.
International Journal of Cancer|February 5, 2010
Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancersByonggu An, Yutaka Kondo, Yasuyuki Okamoto, et al.
Nature Genetics|December 6, 2011
Dnmt3a is essential for hematopoietic stem cell differentiationGrant A Challen, Deqiang Sun, Mira Jeong, et al.
Genome Biology|December 26, 2013
Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transitionGabriel G Malouf, Joseph H Taube, Yue Lu, et al.
Scientific Reports|September 19, 2013
Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell propertiesJoseph H Taube, Gabriel G Malouf, Emily Lu, et al.
Cancer Research|November 6, 2009
Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinomaYasuhiro Goto, Keiko Shinjo, Yutaka Kondo, et al.
Pageof 21

Showing results (181-190 of 209) with videos related to

Sort By:
Pageof 21
Blood|August 3, 2006
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemiaHagop Kantarjian, Yasuhiro Oki, Guillermo Garcia-Manero, et al.
Cancer Research|May 31, 2013
Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastomaAtsushi Natsume, Motokazu Ito, Keisuke Katsushima, et al.
Plos One|December 2, 2011
DNA methylation profiles of primary colorectal carcinoma and matched liver metastasisKazuo Konishi, Yoshiyuki Watanabe, Lanlan Shen, et al.
Toxicology Letters|December 3, 2014
Liver DNA methylation analysis in adult female C57BL/6JxFVB mice following perinatal exposure to bisphenol AJ C J van Esterik, A P Vitins, H M Hodemaekers, et al.
The Lancet. Oncology|August 23, 2015
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 studyJean-Pierre J Issa, Gail Roboz, David Rizzieri, et al.
International Journal of Cancer|February 5, 2010
Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancersByonggu An, Yutaka Kondo, Yasuyuki Okamoto, et al.
Nature Genetics|December 6, 2011
Dnmt3a is essential for hematopoietic stem cell differentiationGrant A Challen, Deqiang Sun, Mira Jeong, et al.
Genome Biology|December 26, 2013
Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transitionGabriel G Malouf, Joseph H Taube, Yue Lu, et al.
Scientific Reports|September 19, 2013
Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell propertiesJoseph H Taube, Gabriel G Malouf, Emily Lu, et al.
Cancer Research|November 6, 2009
Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinomaYasuhiro Goto, Keiko Shinjo, Yutaka Kondo, et al.
Pageof 21